Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
about
Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical ImagingAn update on anticancer drug development and delivery targeting carbonic anhydrase IX.Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy.
P2860
Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@en
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@nl
type
label
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@en
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@nl
prefLabel
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@en
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@nl
P2093
P2860
P1476
Evaluation of Nonpeptidic Liga ...... hydrase IX-Expressing Cancers.
@en
P2093
Karson S Putt
Peng-Cheng Lv
Philip S Low
P2860
P304
P356
10.1021/ACS.BIOCONJCHEM.6B00271
P577
2016-06-30T00:00:00Z